Sign up
Quantellect · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
RepublicanSenate

Tommy Tuberville bought AbbVie Inc (NYSE: ABBV)

Tommy Tuberville (R-AL), a U.S. Senator, has disclosed 7 trades in AbbVie Inc (ABBV) since 2022, 3 purchases and 4 sales, worth an estimated $56K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Tommy Tuberville bought $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on March 30, 2022. Since that trade, ABBV is up +87.58% against the S&P 500 up +68.06%, an outperformance of +19.52%.

Across these filings, Tommy Tuberville has been a net seller of ABBV (a buy-to-sell ratio of 0.75). The most recent disclosed ABBV transaction shown was dated April 3, 2024. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
7
Disclosed Vol
$56K
Buys
3
43%
Sells
4
57%
Buy / Sell
0.75
ratio
First → Last
2022–2024

Tommy Tuberville's ABBV trades vs the price

ABBV is up +87.58% since Tommy Tuberville bought on March 30, 2022, versus +68.06% for the S&P 500.

Performance since this trade

Price change since trade
+87.58%
S&P 500 change since trade
+68.06%
Outperformance vs S&P 500
+19.52%

All Tommy Tuberville ABBV trades

TradedTypeSizeReturnEst. profit
April 3, 2024BUY$164.17+60.38%+$4K
January 19, 2024SELL$152.54+72.61%
November 20, 2023SELL$126.84+107.59%
October 17, 2023BUY$136.80+92.47%+$6K
April 3, 2023SELL$142.74+84.46%
March 30, 2022BUY$140.36+87.58%+$5K
January 21, 2022SELL$113.13+132.74%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Tommy Tuberville & ABBV trading FAQ

Is it legal for Tommy Tuberville to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Tommy Tuberville buy ABBV?

Tommy Tuberville disclosed a purchase of $1,001 - $15,000 of AbbVie Inc (ABBV) on March 30, 2022, according to public STOCK Act filings.

How has ABBV performed since Tommy Tuberville's trade?

Since Tommy Tuberville bought ABBV on March 30, 2022, the stock is up +87.58%, versus +68.06% for the S&P 500 over the same period, an outperformance of +19.52%.

How many times has Tommy Tuberville traded ABBV?

Tommy Tuberville has disclosed 7 ABBV trades since 2022 (3 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Tommy Tuberville's ABBV tradesAll congressional filings for AbbVie IncTommy Tuberville's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.